FPAS
MRNA icon

Focus Partners Advisor Solutions’s Moderna MRNA Stock Holding History

Focus Partners Advisor Solutions’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,805
Closed -$333K – 763
2024
Q2 		$333K Buy
+2,805
New +$355K 0.01% 463
2023
Q1 		– Sell
-1,252
Closed -$225K – 380
2022
Q4 		$225K Sell
1,252
-491
-28% -$80.3K 0.02% 303
2022
Q3 		$206K Buy
+1,743
New +$264K 0.01% 375
2022
Q2 		– Sell
-1,271
Closed -$219K – 376
2022
Q1 		$219K Buy
+1,271
New +$214K 0.02% 293

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Focus Partners Advisor Solutions's MRNA Position: Q3 2024 in Review

Focus Partners Advisor Solutions sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,805 shares — an estimated $333K sold.

Focus Partners Advisor Solutions first reported a position in MRNA in Q1 2022 and held it in 4 quarters. The position peaked at $333K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Focus Partners Advisor Solutions reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Focus Partners Advisor Solutions sold 2,805 Moderna shares in Q3 2024, an estimated $333K.
  • Focus Partners Advisor Solutions first reported a position in Moderna in Q1 2022 and held it in 4 quarters.
  • Focus Partners Advisor Solutions's Moderna position peaked at $333K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Focus Partners Advisor Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.